Data from the Alzheimer's Disease Neuroimaging Initiative (ADNI) cohort also showed that plasma biomarker profiles differed across APOE genotype carrier groups in patients with AD dementia, mild cognitive impairment, and cognitively normal participants (Soares et al., 2012). The gene discussed is APOE; the disease is Alzheimer disease.